Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Liver Int. 2014 May;34(5):802-13. doi: 10.1111/liv.12447. Epub 2014 Jan 24.
BACKGROUND & AIMS: Various modalities have been employed effectively according to the tumour recurrence status in patients with hepatocellular carcinoma (HCC) undergoing hepatectomy. Therefore, their overall prognosis depends largely on the pattern of recurrence/treatment. We investigated the patterns of recurrence and prognosis in HCC patients, especially in relation to the hepatitis virus infection status.
The study population comprised 244 patients with HCC undergoing hepatectomy. Curative treatments, including repeated hepatectomies, were performed for recurrences, whenever possible. Detailed information on recurrences was collected until the recurrences exceeded Milan criteria.
The 5-year disease-free survival, survival within the Milan criteria and overall survival were 38.4%, 56.3% and 74.5% respectively. In the comparison between patients with hepatitis C and B virus-related HCC (HC-HCC: n = 122; and HB-HCC: n = 45 respectively), the former showed lower disease-free (30.2% vs. 40.7% at 5 years, P = 0.061) and overall (65.7% vs. 89.7% at 5 years, P = 0.011) survivals; they also showed a higher incidence of multinodular (≥4) intrahepatic recurrences (19.4% vs. 5.3% at 3 years, P = 0.010). However, the incidences of recurrences exceeding the Milan criteria because of other components were comparable. Patients with HC-HCC showed a higher incidence of intrahepatic recurrences characterized by multiple lesions and the difference became increasingly more pronounced with time.
Patients with HC-HCC were associated with a higher carcinogenesis in the background liver than those with HB-HCC, and this difference was aggravated with time after hepatic resection.
根据肝细胞癌(HCC)患者接受肝切除术后的肿瘤复发情况,各种治疗方式都取得了显著效果。因此,他们的总体预后在很大程度上取决于复发/治疗模式。我们研究了 HCC 患者的复发模式和预后,特别是与肝炎病毒感染状态的关系。
本研究纳入了 244 例行肝切除术的 HCC 患者。尽可能对复发灶采用重复肝切除术等治愈性治疗。详细收集复发情况信息,直至复发灶超过米兰标准。
5 年无病生存率、符合米兰标准的生存率和总生存率分别为 38.4%、56.3%和 74.5%。在丙型肝炎病毒(HCV)和乙型肝炎病毒(HBV)相关 HCC 患者(HC-HCC:n=122;HB-HCC:n=45)之间进行比较时,前者无病生存率(5 年时为 30.2% vs. 40.7%,P=0.061)和总生存率(5 年时为 65.7% vs. 89.7%,P=0.011)较低;前者肝内多发(≥4 个)复发的发生率也较高(3 年时为 19.4% vs. 5.3%,P=0.010)。然而,因其他因素导致超出米兰标准的复发发生率相当。HC-HCC 患者的肝内复发以多发病变为特征,且这种差异随着时间的推移越来越明显。
与 HB-HCC 患者相比,HC-HCC 患者的背景肝中发生癌变的风险更高,这种差异在肝切除术后随着时间的推移而加剧。